PGNX
Progenics Pharmaceuticals Inc
PGNX
PGNX
Delisted
PGNX was delisted on the 19th of June, 2020.
78 hedge funds and large institutions have $293M invested in Progenics Pharmaceuticals Inc in 2014 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 21 increasing their positions, 26 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
19% less repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 26
Holders
78
Holding in Top 10
1
Calls
$1.33M
Puts
$1.11M
Top Buyers
| 1 | +$12M | |
| 2 | +$6.7M | |
| 3 | +$5.02M | |
| 4 |
RA
Royce & Associates
New York
|
+$3.53M |
| 5 |
FM
Forward Management
San Francisco,
California
|
+$3.01M |
Top Sellers
| 1 | -$1.57M | |
| 2 | -$570K | |
| 3 | -$404K | |
| 4 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
-$391K |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$381K |